David M. Mott - Director at Epizyme, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by David M. Mott since 04 Aug 2025

Reported holdings for David M. Mott in Epizyme, Inc.

Form 4 holding Director

Epizyme, Inc.

Security class
Common Stock, par value $0.0001
Shares / value
0
Estimated value
Report date
12 Aug 2022
Price
$1.41
Ownership
Direct
Form 4 holding Director

Epizyme, Inc.

Security class
Common Stock, par value $0.0001
Shares / value
0
Estimated value
Report date
12 Aug 2022
Price
$1.41
Ownership
Indirect

Transaction history for David M. Mott in Epizyme, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .